Clinical Trial

Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion

Study acronym: SEMFERTIL
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study was to obtain short- and long-term performance and safety data of cross-linked hyaluronic acid-based adhesion barrier gel used to prevent intrauterine adhesion formation.
Trial Details
NCT Number NCT07160764
Lead Sponsor Semikal Technology
Collaborators: Antalya Training and Research Hospital
Conditions Intrauterine Abnormalities in Infertility, Asherman Syndrome, Intra-uterine Adhesions, Postoperative Adhesion of Uterus, Asherman's Syndrome
Enrollment 80 participants
Start Date 2025-11-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-08